A rigorous analysis of randomized controlled trials involving patients with type 2 diabetes evaluated clinically meaningful outcomes (such as a hemoglobin A1C < 7% or a 0.5% or greater decrease in hemoglobin A1C) and found that at best chromium supplementation provides a small benefit.